The market for Parkinson’s disease (PD) drugs across the seven major geographies (7MM; USA, France, Germany, Italy, UK and ...

( MENAFN - IANS) New Delhi, Feb 4 (IANS) The global Parkinson's disease (PD) market is expected to grow to $7.9 billion by 2033 from $3.4 billion in 2023, according to a report.

Research analysts at Leerink Partnrs issued their Q1 2025 EPS estimates for shares of Tango Therapeutics in a research report issued to clients and investors on Wednesday, February 5th. Leerink ...

Tango Therapeutics, Inc.’s TNGX share price has surged by 10.20%, which has investors questioning if this is right time to sell.

Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable periods in 2023.

DNA methyltransferase inhibitors. 2′-deoxy-5-azacytidine (DAC) is a chemical analogue of cytidine nucleoside. The incorporation of DAC into DNA or RNA inhibits DNA methyltransferase, thereby ...

DOT1L is the only lysine methyltransferase that does not contain a SET domain, which is a feature that allowed the development of selective DOT1L inhibitors that are currently investigated in Phase I ...

This manuscript reports important findings that the methyltransferase METTL3 is involved in the ... Comparable results were observed upon treatment with raltitrexed, an inhibitor of thymidylate ...

Trends Pharmacol Sci 30:55-60. Kundakovic M, Chen Y, Costa E, Grayson DRH. (2007) DNA Methyltransferase Inhibitors Coordinately Induce Expression of the Human Reelin and Glutamic Acid Decarboxylase 67 ...

In recent years, cancer immunotherapy has made remarkable achievements. Immune checkpoint inhibitors (ICIs) have been used successfully in several types of cancer in the past decade. However, expanded ...